» Articles » PMID: 16235186

The Unexpected Impact of a Chlamydia Trachomatis Infection Control Program on Susceptibility to Reinfection

Overview
Journal J Infect Dis
Date 2005 Oct 20
PMID 16235186
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Background: After the introduction of a program to control Chlamydia trachomatis infection in British Columbia, Canada, case rates fell from 216 cases/100,000 population in 1991 to 104 cases/100,000 population in 1997. Since 1998, rates have increased, and case counts now exceed those recorded before the intervention.

Methods: We used Cox proportional-hazards survival analysis and developed a compartmental mathematical model to investigate the cause of resurgence in chlamydia cases.

Results: Cox proportional-hazards survival analysis showed that the relative risk of C. trachomatis reinfection has increased 4.6% per year since 1989, with the increased risk greatest among the young and greater among women than men. A compartmental mathematical model of C. trachomatis transmission showed that a control strategy based on shortening the average duration of infection results in an early reduction in prevalence followed by a rebound in prevalence, reproducing the observed trends.

Conclusions: We speculate that a C. trachomatis infection control program based on early case identification and treatment interferes with the effects of immunity on population susceptibility to infection and that, in the absence of strategies to alter sexual networks, a vaccine will be needed to halt the spread of infection at the population level.

Citing Articles

Impact of a potential Chlamydia vaccine in the USA: mathematical modelling analyses.

Makhoul M, Ayoub H, Awad S, Chemaitelly H, Abu-Raddad L BMJ Public Health. 2025; 2(1):e000345.

PMID: 40018092 PMC: 11812766. DOI: 10.1136/bmjph-2023-000345.


Low-Frequency, Sustained CD4 T-Cell Responses Chlamydia trachomatis in Women: Predominant Targeting of Chlamydial Proteaselike Activity Factor (CPAF).

Li Y, Warren J, Poston T, Clutton G, Shaw F, Conrad S J Infect Dis. 2024; 231(2):e385-e395.

PMID: 39250505 PMC: 11841636. DOI: 10.1093/infdis/jiae443.


Viral Vector-Based Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice.

Andreacchio G, Longo Y, Moreno Mascaraque S, Anandasothy K, Tofan S, Ozun E Vaccines (Basel). 2024; 12(8).

PMID: 39204067 PMC: 11360449. DOI: 10.3390/vaccines12080944.


Structural Assessment of Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds.

Roe S, Zhu T, Slepenkin A, Berges A, Fairman J, de la Maza L Vaccines (Basel). 2024; 12(7).

PMID: 39066427 PMC: 11281497. DOI: 10.3390/vaccines12070789.


Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG.

Slepenkin A, Pal S, Rasley A, Coleman M, de la Maza L NPJ Vaccines. 2024; 9(1):104.

PMID: 38858418 PMC: 11164897. DOI: 10.1038/s41541-024-00880-6.